Find trials
Search tips

Intra-Patient Tumor Heterogeneity in Patients with Solid Tumors

Overview

About this study

The purpose of this study is to identify clonal eveolation of tumors by genomically altered DNA sequences resulting from copy number alterations in tumors at initial diagnosis and on recurrence.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Patients must have a diagnosis of a solid tumor
  • Patients must have availability of tumor tissue from at least 2 separate areas either from a primary and metastatic lesion or two separate metastasis.
  • ≥18 years of age

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Ramesh Ramanathan, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

More about research at Mayo Clinic

.
CLS-20305071

Mayo Clinic Footer